Cipralex
Epilepsy, Temporal Lobe
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Epilepsy, Temporal Lobe cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nrtx-1001 Neurona Therapeutics | Phase 3 | BB |
NALUZOTAN National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 | CCC |
Ferumoxytol University of Alberta | Phase 2 | CCC |
Same molecule, other indications
Cipralex is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →